PPA
VTVT icon

Parametric Portfolio Associates’s vTv Therapeutics VTVT Stock Holding History

Parametric Portfolio Associates’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-311
Closed -$28K – 3665
2021
Q2 		$28K Sell
311
-344
-53% -$34.8K ﹤0.01% 3553
2021
Q1 		$74K Buy
655
+189
+41% +$18.6K ﹤0.01% 3996
2020
Q4 		$35K Buy
+466
New +$35.7K ﹤0.01% 3963
2018
Q3 		– Sell
-543
Closed -$33K – 3975
2018
Q2 		$33K Buy
+543
New +$40.1K ﹤0.01% 3863
2016
Q1 		– Sell
-431
Closed -$117K – 4040
2015
Q4 		$117K Buy
+431
New +$121K ﹤0.01% 3839

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAG
Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

Parametric Portfolio Associates's VTVT Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of vTv Therapeutics (VTVT) in Q3 2021, closing a stake of 311 shares — an estimated $28K sold.

Parametric Portfolio Associates first reported a position in VTVT in Q4 2015 and held it in 5 quarters. The position peaked at $117K in Q4 2015. 31 funds tracked by Wall St. Rank hold VTVT as of Q3 2021.

  • Parametric Portfolio Associates reported no remaining vTv Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 311 vTv Therapeutics shares in Q3 2021, an estimated $28K.
  • Parametric Portfolio Associates first reported a position in vTv Therapeutics in Q4 2015 and held it in 5 quarters.
  • Parametric Portfolio Associates's vTv Therapeutics position peaked at $117K in Q4 2015.
  • 31 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.